{
    "clinical_study": {
        "@rank": "60268", 
        "acronym": "NEFIGAN", 
        "arm_group": [
            {
                "arm_group_label": "NEFECON 8 mg/day", 
                "arm_group_type": "Experimental", 
                "description": "NEFECON 8 mg/day (2 active + 2 placebo capsules daily) for 9 months"
            }, 
            {
                "arm_group_label": "NEFECON 16 mg/day", 
                "arm_group_type": "Experimental", 
                "description": "NEFECON 16 mg/day (4 active capsules daily) for 9 months"
            }, 
            {
                "arm_group_label": "Placebo", 
                "arm_group_type": "Placebo Comparator", 
                "description": "Placebo (4 placebo capsules daily) for 9 months"
            }
        ], 
        "brief_summary": {
            "textblock": "The objective of the study is to evaluate efficacy and safety of two different doses of\n      NEFECON in the treatment of patients with primary IgA nephropathy (IgAN) at risk of\n      developing end-stage renal disease, under rigorous blood pressure control with an\n      angiotensin-converting enzyme inhibitor (ACEI) and/or angiotensin II receptor I blocker\n      (ARB)."
        }, 
        "brief_title": "The Effect of Nefecon\u00ae in Patients With Primary IgA Nephropathy at Risk of Developing End-stage Renal Disease", 
        "completion_date": {
            "#text": "September 2015", 
            "@type": "Anticipated"
        }, 
        "condition": "Primary IgA Nephropathy", 
        "condition_browse": {
            "mesh_term": [
                "Glomerulonephritis, IGA", 
                "Kidney Diseases", 
                "Kidney Failure, Chronic"
            ]
        }, 
        "detailed_description": {
            "textblock": "NEFECON is an add-on treatment to other medications for nephropathy symptoms and kidney\n      function, including ACEI and/or ARBs. Rigorous blood pressure control will be achieved over\n      a 6-month Run-in Phase in which ACEI and/or ARB will be dosed to target a blood pressure of\n      <130/80 mm Hg and UPCR <0.5 g/g. Patients who complete the Run-in Phase, and despite\n      optimized ACEI and/or ARB therapy, have a UPCR \u22650.5 g/g OR urine protein \u22650.75 g/24hr will\n      be eligible for randomization and entry into the treatment phase of the trial. Patients will\n      remain on their ACEI and/or ARB dosing regimen for the duration of the trial.\n\n      Patients entering the treatment phase will be administered NEFECON (8 mg/day OR 16 mg/day)\n      OR placebo for a phase of 9 months. A 3-month follow-up phase will follow on from the\n      treatment phase, of which the first 2 weeks will be used to taper the dose of those patients\n      that received 16 mg/day dosing to 8 mg/day, with the placebo and 8 mg/day groups receiving\n      placebo to retain blinding."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Screening Inclusion Criteria:\n\n          1. Female or male patients \u226518 years\n\n          2. Biopsy-verified IgA nephropathy\n\n          3. Urine protein creatinine ratio \u22650.5 g/g OR urine protein \u22650.75 g/24hr\n\n          4. Estimated GFR (using the CKD-EPI formula) OR measured GFR \u226550 mL/min per 1.73 m2 OR\n             \u226545 mL/min per 1.73m2 for patients on a maximum recommended or maximum tolerated dose\n             of an ACEI and/or ARB\n\n          5. Willing to change antihypertensive medication regimen if applicable\n\n          6. Willing and able to give informed consent\n\n        Screening Exclusion Criteria:\n\n          1. Secondary forms of IgA nephropathy as defined by the treating physician (for example,\n             Henoch-Sch\u00f6nlein purpura patients and those with associated alcoholic cirrhosis)\n\n          2. Presence of crescent formation in \u226550% of glomeruli assessed on renal biopsy\n\n          3. Kidney transplanted patients 4. Severe gastrointestinal disorders (including peptic\n             ulcer disease and inflammatory bowel disease) which may impair drug effect, or other\n             conditions which could modify the effect of the trial drug as judged by the\n             Investigator\n\n          4. Patients currently treated with systemic immunosuppressive or systemic corticosteroid\n             drugs (excluding topical or nasal steroids) or have been previously treated for more\n             than one week within the last 24 months.\n\n          5. Patients currently treated chronically (daily dosing) with inhaled corticosteroid\n             drugs or have previously been treated chronically for more than one month within the\n             last 12 months\n\n          6. Patients previously treated with immunosuppressive or systemic corticosteroids for\n             the treatment of IgA nephropathy\n\n          7. Patients unable to take oral medication or intolerant to budesonide or other\n             corticosteroid preparations\n\n          8. Patients with known allergy or intolerance to ACEI, ARB or to any component of the\n             trial drug formulation\n\n          9. Patients with acute or chronic infectious disease incl. hepatitis, HIV positive\n             patients and patients with chronic urinary tract infections\n\n         10. Severe liver disease according to the discretion of the Investigator\n\n         11. Patients with Type 1 or 2 diabetes\n\n         12. Patients with uncontrolled cardiovascular disease as judged by the Investigator\n\n         13. Patients with current malignancy or history of malignancy during the last three years\n\n         14. For women only; pregnant or breast feeding or unwilling to use adequate contraception\n             during the trial (only women of child bearing potential)\n\n        Randomization Inclusion Criteria:\n\n          1. Completion of the Run-in Phase\n\n          2. Urine protein creatinine ratio \u22650.5 g/g OR urine protein \u22650.75 g/24hr\n\n          3. eGFR \u226545 mL/min per 1.73 m2 using CKD-EPI formula OR measured GFR \u226545 mL/min per 1.73\n             m2\n\n        Randomization Exclusion Criteria:\n\n          1. Unacceptable blood pressure defined as a systolic value >160 mm Hg or diastolic >100\n             mm Hg\n\n          2. eGFR (CKD-EPI) loss >30% over the entire duration of the Run-in Phase\n\n          3. For women only; pregnant or breast feeding or unwilling to use adequate contraception\n             during the trial (only women of child bearing potential)"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "90", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "July 25, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01738035", 
            "org_study_id": "Nef-202", 
            "secondary_id": "2012-001923-11"
        }, 
        "intervention": [
            {
                "arm_group_label": [
                    "NEFECON 8 mg/day", 
                    "NEFECON 16 mg/day"
                ], 
                "description": "All patients will receive a maximum recommended daily dose of an ACEI and/or ARB (or maximum tolerated dose not exceeding the maximum recommended daily dose) for the duration of the treatment and follow-up phases.", 
                "intervention_name": "NEFECON", 
                "intervention_type": "Drug", 
                "other_name": "Budesonide modified-released capsules (4 mg/capsule)"
            }, 
            {
                "arm_group_label": "Placebo", 
                "description": "All patients will receive a maximum recommended daily dose of an ACEI and/or ARB (or maximum tolerated dose not exceeding the maximum recommended daily dose) for the duration of the treatment and follow-up phases.", 
                "intervention_name": "Placebo", 
                "intervention_type": "Other"
            }
        ], 
        "is_fda_regulated": "No", 
        "keyword": "IgA nephropathy", 
        "lastchanged_date": "January 8, 2014", 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "Antwerp", 
                        "country": "Belgium"
                    }, 
                    "name": "University Hospital of Antwerp"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Bonheiden", 
                        "country": "Belgium"
                    }, 
                    "name": "Imelda Hospital"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Ghent", 
                        "country": "Belgium"
                    }, 
                    "name": "Ghent University Hospital"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Leuven", 
                        "country": "Belgium"
                    }, 
                    "name": "University Hospitals Leuven"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Roeselare", 
                        "country": "Belgium"
                    }, 
                    "name": "Heilig Hartziekenhuis Roeselare-Menen"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Olomouc", 
                        "country": "Czech Republic"
                    }, 
                    "name": "University Hospital"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Prague", 
                        "country": "Czech Republic"
                    }, 
                    "name": "Charles University & General University Hospital"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Prague", 
                        "country": "Czech Republic"
                    }, 
                    "name": "Institut klinick\u00e9 a experiment\u00e1ln\u00ed medic\u00edny"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Copenhagen", 
                        "country": "Denmark"
                    }, 
                    "name": "Rigshospitalet"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Herlev", 
                        "country": "Denmark"
                    }, 
                    "name": "Herlev Hospital"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Odense", 
                        "country": "Denmark"
                    }, 
                    "name": "Odense University Hospital"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Helsinki", 
                        "country": "Finland"
                    }, 
                    "name": "Helsinki University Central Hospital"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Tampere", 
                        "country": "Finland"
                    }, 
                    "name": "Tampere University Hospital"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Turku", 
                        "country": "Finland"
                    }, 
                    "name": "Turku University Central Hospital"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Aachen", 
                        "country": "Germany"
                    }, 
                    "name": "RWTH Aachen"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Augsburg", 
                        "country": "Germany"
                    }, 
                    "name": "Klinikum Augsburg"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Berlin", 
                        "country": "Germany"
                    }, 
                    "name": "Charit\u00e9-Virchow Clinic"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Berlin", 
                        "country": "Germany"
                    }, 
                    "name": "Charit\u00e9 Hospital"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Berlin", 
                        "country": "Germany"
                    }, 
                    "name": "Vivantes Klinikum im Friedrichshain"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Bremen", 
                        "country": "Germany"
                    }, 
                    "name": "Klinikum-Bremen-Mitte"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Dresden", 
                        "country": "Germany"
                    }, 
                    "name": "University Hospital Carl Gustav Carus"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "D\u00fcsseldorf", 
                        "country": "Germany"
                    }, 
                    "name": "Studienzentrum Karlstrasse"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Erlangen", 
                        "country": "Germany"
                    }, 
                    "name": "Universit\u00e4tsklinikum Erlangen"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "G\u00f6ttingen", 
                        "country": "Germany"
                    }, 
                    "name": "Universit\u00e4tsmedizin G\u00f6ttingen"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Heidelberg", 
                        "country": "Germany"
                    }, 
                    "name": "University Hospital"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Jena", 
                        "country": "Germany"
                    }, 
                    "name": "University of Jena"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Magdeburg", 
                        "country": "Germany"
                    }, 
                    "name": "Universit\u00e4tsklinikum Magdeburg"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Munich", 
                        "country": "Germany"
                    }, 
                    "name": "Universit\u00e4t M\u00fcnchen"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "M\u00fcnster", 
                        "country": "Germany"
                    }, 
                    "name": "Universit\u00e4tsklinikum M\u00fcnster"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Regensburg", 
                        "country": "Germany"
                    }, 
                    "name": "Universit\u00e4tsklinikum Regensburg"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Wiesbaden", 
                        "country": "Germany"
                    }, 
                    "name": "Deutsche Klinik f\u00fcr Diagnostik"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "W\u00fcrzburg", 
                        "country": "Germany"
                    }, 
                    "name": "W\u00fcrzburg University Hospital"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Bari", 
                        "country": "Italy"
                    }, 
                    "name": "Policlinico di Bari"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Cagliari", 
                        "country": "Italy"
                    }, 
                    "name": "Azienda Ospedaliera G. Brotzu"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Lecco", 
                        "country": "Italy"
                    }, 
                    "name": "Ospedale A Manzoni"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Milano", 
                        "country": "Italy"
                    }, 
                    "name": "Bassini Hospital"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Torino", 
                        "country": "Italy"
                    }, 
                    "name": "Ospedale S. G. Bosco"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Viterbo", 
                        "country": "Italy"
                    }, 
                    "name": "Belcolle Hospital"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Leiden", 
                        "country": "Netherlands"
                    }, 
                    "name": "University Medical Center"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Barcellona", 
                        "country": "Spain"
                    }, 
                    "name": "Hospital Universitario Vall d'Hebron"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Barcellona", 
                        "country": "Spain"
                    }, 
                    "name": "Fundaci\u00f3n Puigver"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Madrid", 
                        "country": "Spain"
                    }, 
                    "name": "Fundaci\u00f3n Jimenez Diaz Hospital"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Madrid", 
                        "country": "Spain"
                    }, 
                    "name": "Hospital Universitario Gregorio Mara\u00f1on"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Madrid", 
                        "country": "Spain"
                    }, 
                    "name": "12 de Octubre Hospital"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Karlstad", 
                        "country": "Sweden"
                    }, 
                    "name": "Central sjukhuset"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Karlstad", 
                        "country": "Sweden"
                    }, 
                    "name": "Karlstad Central Hospital"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Link\u00f6ping", 
                        "country": "Sweden"
                    }, 
                    "name": "University Hospital"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Stockholm", 
                        "country": "Sweden"
                    }, 
                    "name": "Karolinska University Hospital"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Stockholm", 
                        "country": "Sweden"
                    }, 
                    "name": "Danderyds Hospital"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Uppsala", 
                        "country": "Sweden"
                    }, 
                    "name": "Uppsala University Hospital"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Belfast", 
                        "country": "United Kingdom"
                    }, 
                    "name": "Belfast City Hospital"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Belfast", 
                        "country": "United Kingdom"
                    }, 
                    "name": "Ulster Hospital"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Derby", 
                        "country": "United Kingdom"
                    }, 
                    "name": "Royal Derby Hospital"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Edinburgh", 
                        "country": "United Kingdom"
                    }, 
                    "name": "Edinburgh Royal Infirmary"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Glasgow", 
                        "country": "United Kingdom"
                    }, 
                    "name": "Western Infirmary"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Leeds", 
                        "country": "United Kingdom"
                    }, 
                    "name": "The Leeds Teaching Hospitals NHS Trust"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Leicester", 
                        "country": "United Kingdom"
                    }, 
                    "name": "Leicester General Hospital"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Middlesbrough", 
                        "country": "United Kingdom"
                    }, 
                    "name": "James Cook University Hospital"
                }
            }
        ], 
        "location_countries": {
            "country": [
                "Belgium", 
                "Czech Republic", 
                "Denmark", 
                "Finland", 
                "Germany", 
                "Italy", 
                "Netherlands", 
                "Spain", 
                "Sweden", 
                "United Kingdom"
            ]
        }, 
        "number_of_arms": "3", 
        "official_title": "A Multicentre, Interventional Treatment, Randomized, Double-Blind, Placebo Controlled Study to Evaluate the Efficacy and Safety of Two Different Doses of Nefecon in Primary IgA Nephropathy Patients at Risk of End-stage Renal Disease", 
        "other_outcome": [
            {
                "measure": "Change from baseline in urine protein creatinine ratio", 
                "safety_issue": "No", 
                "time_frame": "3-12 months"
            }, 
            {
                "measure": "Change in urine albumin creatinine ratio", 
                "safety_issue": "No", 
                "time_frame": "3-12 months"
            }, 
            {
                "measure": "Change from baseline in 24 hour albuminuria", 
                "safety_issue": "No", 
                "time_frame": "3-12 months"
            }, 
            {
                "measure": "Change from baseline in estimated GFR", 
                "safety_issue": "No", 
                "time_frame": "3-12 months"
            }
        ], 
        "overall_official": [
            {
                "affiliation": "Professor of Medicine Department of Medical Sciences, Renal Medicine Uppsala University Hospital, Sweden", 
                "last_name": "Bengt Fellstr\u00f6m, MD, PhD", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "Pharmalink AB, Stockholm, Sweden", 
                "last_name": "Alex Mercer, PhD", 
                "role": "Study Director"
            }
        ], 
        "overall_status": "Active, not recruiting", 
        "oversight_info": {
            "authority": [
                "Belgium: Federal Agency for Medicinal Products and Health Products", 
                "Czech Republic: State Institute for Drug Control", 
                "Denmark: Danish Medicines Agency", 
                "Finland: Finnish Medicines Agency", 
                "Germany: Federal Institute for Drugs and Medical Devices", 
                "Italy: The Italian Medicines Agency", 
                "Netherlands: The Central Committee on Research Involving Human Subjects (CCMO)", 
                "Spain: Spanish Agency of Medicines", 
                "Sweden: Medical Products Agency", 
                "United Kingdom: Medicines and Healthcare Products Regulatory Agency"
            ], 
            "has_dmc": "Yes"
        }, 
        "phase": "Phase 2", 
        "primary_completion_date": {
            "#text": "June 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "Change from baseline in urine protein creatinine ratio", 
            "safety_issue": "No", 
            "time_frame": "9 months"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01738035"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "measure": "Change from baseline in urine albumin creatinine ratio", 
                "safety_issue": "No", 
                "time_frame": "9 months"
            }, 
            {
                "measure": "Change from baseline in 24 hour albuminuria", 
                "safety_issue": "No", 
                "time_frame": "9 months"
            }, 
            {
                "measure": "Change from baseline in estimated GFR", 
                "safety_issue": "No", 
                "time_frame": "9 months"
            }
        ], 
        "source": "Pharmalink AB", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Pharmalink AB", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "December 2012", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "January 2014"
    }
}